PRO-ACTIVE:
Comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer
In collaboration with Julie Theurer (Assistant Professor, Western University) and Dr. David Palma (Radiation Oncologist, LHSC), LHSC Speech-Language Pathologists, Meaghan Prouse, Colleen Dreyer, Kendra Thouless and Sarah Hawkins are participating in a multicentre randomized clinical trial (known as PROACTIVE) examining the effectiveness of pro-active vs. re-active swallowing therapy for individuals receiving radiotherapy for head and neck cancer. This trial is poised to provide practice-shaping evidence for speech-language pathology in this patient population worldwide.
